OTC · Financial Statements
Biotricity, Inc. (BTCY) Financial Statements
$0.10
OTC: BTCY
Market Cap $2.74M
Biotricity, Inc. most recently reported annual revenue of $16.0M, a net loss of $2.0M. Revenue grew at an average annual rate of 39.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.